AMIXAN 500 contains Amikacin 500 mg Injection, providing potent aminoglycoside antibacterial activity for serious susceptible infections. A strong PCD Pharma Injectable Antibiotic offering.
Serious susceptible bacterial infections.
Kidney function and auditory function may require monitoring.
Administer only as prescribed by a qualified healthcare professional. Adequate hydration and renal monitoring are important. Avoid concurrent nephrotoxic/ototoxic drugs where possible.
Nephrotoxicity, hearing impairment, dizziness, nausea and injection-site reactions may occur.
AMIXAN 500: Amikacin disrupts bacterial protein synthesis by binding to the 30S ribosomal subunit, resulting in bacterial death.
